BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 5635756)

  • 1. Inactivated African horse sickness virus cell culture vaccine.
    Mirchamsy H; Taslimi H
    Immunology; 1968 Jan; 14(1):81-8. PubMed ID: 5635756
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunization of horses against African horse-sickness with attenuated neurotropic viral strains propagated in chicken embryos.
    Goldsmit L
    Am J Vet Res; 1968 Jan; 29(1):133-41. PubMed ID: 4295122
    [No Abstract]   [Full Text] [Related]  

  • 3. AFRICAN HORSE-SICKNESS LIVE-VIRUS TISSUE CULTURE VACCINE.
    OZAWA Y; HAZRATI A; EROL N
    Am J Vet Res; 1965 Jan; 26():154-68. PubMed ID: 14266922
    [No Abstract]   [Full Text] [Related]  

  • 4. Immunity to bivalent tissue culture origin equine encephalomyelitis vaccine.
    Gutekunst DE
    J Am Vet Med Assoc; 1969 Jul; 155(2):368-74. PubMed ID: 5816119
    [No Abstract]   [Full Text] [Related]  

  • 5. Development of a modified virus strain and vaccine for equine viral arteritis.
    McCollum WH
    J Am Vet Med Assoc; 1969 Jul; 155(2):318-22. PubMed ID: 4978804
    [No Abstract]   [Full Text] [Related]  

  • 6. Serological responses of horses immunized with live attenuated African horse sickness vaccine.
    Mirchamsy H; Taslimi H
    J Comp Pathol; 1967 Oct; 77(4):431-8. PubMed ID: 4295721
    [No Abstract]   [Full Text] [Related]  

  • 7. Immunization against equine viral arteritis using modified live virus propagated in cell cultures of rabbit kidney.
    Doll ER; Bryans JT; Wilson JC; McCollum WH
    Cornell Vet; 1968 Oct; 48(4):497-524. PubMed ID: 4971878
    [No Abstract]   [Full Text] [Related]  

  • 8. African horse-sickness killed-virus tissue culture vaccine.
    Ozawa Y; Bahrami S
    Can J Comp Med Vet Sci; 1966 Nov; 30(11):311-4. PubMed ID: 4226381
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Post-vaccination reactions in donkeys vaccinated with African horse-sickness polyvalent vaccines.
    Ozawa Y; Hazrati A
    Bull Off Int Epizoot; 1967; 67(7):949-59. PubMed ID: 4303690
    [No Abstract]   [Full Text] [Related]  

  • 10. Some properties of avirulent cold variants of African horse sickness virus.
    Mirchamsy H; Taslimi H
    Res Vet Sci; 1967 Apr; 8(2):195-200. PubMed ID: 4962856
    [No Abstract]   [Full Text] [Related]  

  • 11. Letter: AHS vaccine.
    Dvies FG
    Vet Rec; 1976 Jan; 98(2):36. PubMed ID: 1258291
    [No Abstract]   [Full Text] [Related]  

  • 12. Venezuelan equine encephalomyelitis: antibody response in vaccinated horses and resistance to infection with virulent virus.
    Jochim MM; Barber TL; Luedke AJ
    J Am Vet Med Assoc; 1973 Feb; 162(4):280-3. PubMed ID: 4686185
    [No Abstract]   [Full Text] [Related]  

  • 13. Experiences with new generation vaccines against equine viral arteritis, West Nile disease and African horse sickness.
    MacLachlan NJ; Balasuriya UB; Davis NL; Collier M; Johnston RE; Ferraro GL; Guthrie AJ
    Vaccine; 2007 Jul; 25(30):5577-82. PubMed ID: 17267078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunogenicity of two adjuvant formulations of an inactivated African horse sickness vaccine in guinea-pigs and target animals.
    Ronchi GF; Ulisse S; Rossi E; Franchi P; Armillotta G; Capista S; Peccio A; Di Ventura M; Pini A
    Vet Ital; 2012; 48(1):55-76. PubMed ID: 22485003
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biologic requirements and control of equine viral arteritis vaccine.
    LaSalle B
    J Am Vet Med Assoc; 1969 Jul; 155(2):323-6. PubMed ID: 4980061
    [No Abstract]   [Full Text] [Related]  

  • 16. Interference between African horse-sickness viruses in tissue culture.
    Ozawa Y
    Zahnarztl Prax; 1966 Jan; 17(2):106-9. PubMed ID: 4958274
    [No Abstract]   [Full Text] [Related]  

  • 17. [Preliminary note on use of an inactivated vaccine against equine plague].
    Bourdin P; Monnier-Cambon J
    Bull Acad Vet Fr; 1967 Apr; 40(4):187-91. PubMed ID: 4309539
    [No Abstract]   [Full Text] [Related]  

  • 18. VP2 Exchange and NS3/NS3a Deletion in African Horse Sickness Virus (AHSV) in Development of Disabled Infectious Single Animal Vaccine Candidates for AHSV.
    van de Water SG; van Gennip RG; Potgieter CA; Wright IM; van Rijn PA
    J Virol; 2015 Sep; 89(17):8764-72. PubMed ID: 26063433
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Definitive efficacy and safety testing for equine encephalomyelitis vaccine.
    Hays MB
    J Am Vet Med Assoc; 1969 Jul; 155(2):374-6. PubMed ID: 5816120
    [No Abstract]   [Full Text] [Related]  

  • 20. Inactivated and adjuvanted vaccine for the control of the African horse sickness virus serotype 9 infection: evaluation of efficacy in horses and guinea-pig model.
    Lelli R; Molini U; Ronchi GF; Rossi E; Franchi P; Ulisse S; Armillotta G; Capista S; Khaiseb S; Di Ventura M; Pini A
    Vet Ital; 2013; 49(1):89-98. PubMed ID: 23564590
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.